慢性呼吸系统疾病管理的现状和展望

doi:10.19983/j.issn.2096-8493.2024146

结核与肺部疾病杂志 ›› 2024, Vol. 5 ›› Issue (6): 567-572.doi: 10.19983/j.issn.2096-8493.2024146

慢性呼吸系统疾病管理的现状和展望

朱衣兴¹^,², 常德¹^,³()

¹中国人民解放军总医院第八医学中心呼吸与危重症医学部,北京 100026
²中国人民解放军总医院研究生院,北京 100853
³中国人民解放军总医院第七医学中心呼吸与危重症医学科,北京 100091

收稿日期:2024-10-04 出版日期:2024-12-20 发布日期:2024-12-11
通信作者: 常德 E-mail:changde@301hospital.com.cn
基金资助:
国家“十四五”重点研发计划青年科学家项目(2021YFC2302300);部队“三才一队”人才工程计划(2021-439);军队高层次科技创新人才工程(2022-QN07351);解放军总医院“3+1”创新人才建设工程学科拔尖人才(20230315);北京市科技新星计划交叉学科合作课题(20220484197)

Current status and prospects of management of chronic respiratory diseases

Zhu Yixing¹^,², Chang De¹^,³()

¹Department of Respiratory and Critical Care Medicine, Eighth Medical Center, Chinese PLA General Hospital, Beijing 100026, China
²General Hospital Graduate School, Chinese PLA General Hospital, Beijing 100853, China
³Department of Respiratory and Critical Care Seventh Medical Center, Chinese PLA General Hospital, Beijing 100091, China

Received:2024-10-04 Online:2024-12-20 Published:2024-12-11
Contact: Chang De E-mail:changde@301hospital.com.cn
Supported by:
The National Key Research and Development Program of China(2021YFC2302300);Talent Project(2021-439);Talent Project(2022-QN07351);Talent Project(20230315);Beijing Nova Program Interdisciplinary Cooperation Project(20220484197)

摘要/Abstract

摘要：

慢性呼吸系统疾病是一组起病隐匿、病程迁延的非传染性疾病,具有病因复杂、治疗费用高昂及预后不良等特点。本综述系统分析了慢性阻塞性肺疾病、哮喘、肺癌及间质性肺病等主要类型的流行病学、病理生理机制及临床管理策略。强调了早期诊断的重要性,探讨了治疗依从性、个体化治疗策略及资源配置等管理挑战,并展望了靶向治疗、基因治疗、数字健康技术等新兴治疗手段的应用前景,旨在为临床医生提供全面的疾病管理视角。

关键词: 肺疾病, 慢性阻塞性, 哮喘, 肺肿瘤, 肺疾病, 间质性, 流行病学研究特征(主题), 卫生服务管理

Abstract:

Chronic respiratory diseases are a group of non-communicable diseases characterized by insidious onset and protracted course, with complex etiology, high treatment costs, and poor prognosis. This review systematically analyzes the epidemiology, pathophysiological mechanisms, and clinical management strategies of major types of chronic respiratory diseases such as chronic obstructive pulmonary disease, asthma, lung cancer, and interstitial lung diseases. The paper highlights the importance of early diagnosis, discusses management challenges such as treatment adherence, individualized treatment strategies and resource allocation, and looks into the future application prospects of emerging therapeutic approaches like targeted therapy, gene therapy, and digital health technologies, aiming to provide clinicians a comprehensive perspective on disease management.

Key words: Pulmonary disease, chronic obstructive, Asthma, Lung neoplasms, Lung diseases, interstitial, Epidemiologic study characteristics as topic, Health services administration

中图分类号:

R714.253

朱衣兴, 常德. 慢性呼吸系统疾病管理的现状和展望[J]. 结核与肺部疾病杂志, 2024, 5(6): 567-572. doi: 10.19983/j.issn.2096-8493.2024146

Zhu Yixing, Chang De. Current status and prospects of management of chronic respiratory diseases[J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 567-572. doi: 10.19983/j.issn.2096-8493.2024146

参考文献 32

[1]	Nugent R. Preventing and managing chronic diseases. BMJ, 2019, 364: l459. doi:10.1136/bmj.l459.
[2]	Institute for Health Metrics and Evaluation. Global Burden of Disease (GBD) 2024. Washington: Institute for Health Metrics and Evaluation, 2024.
[3]	Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. Lancet, 2022, 399(10342): 2227-2242. doi:10.1016/S0140-6736(22)00470-6. pmid: 35533707
[4]	Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990—2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859): 2163-2196. doi:10.1016/S0140-6736(12)61729-2.
[5]	薛敏, 魏小玲, 刘苗, 等. 儿童哮喘起病年龄相关影响因素分析. 结核与肺部疾病杂志, 2024, 5(5): 468-475. doi:10.19983/j.issn.2096-8493.2024089.
[6]	时旭, 陈如冲, 李靖. 哮喘表型和2型炎症哮喘研究进展. 结核与肺部疾病杂志, 2024, 5(5): 489-494. doi:10.19983/j.issn.2096-8493.2024107.
[7]	Porsbjerg C, Melén E, Lehtimäki L, et al. Asthma. Lancet, 2023, 401(10379): 858-873. doi:10.1016/S0140-6736(22)02125-0.
[8]	Olson AL, Patnaik P, Hartmann N, et al. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis. Adv Ther, 2021, 38(7): 4100-4114. doi:10.1007/s12325-021-01786-8. pmid: 34156606
[9]	Wijsenbeek M, Cottin V. Spectrum of Fibrotic Lung Diseases. N Engl J Med, 2020, 383(10): 958-968. doi:10.1056/NEJMra2005230.
[10]	Çolak Y, Afzal S, Nordestgaard BG, et al. Importance of Early COPD in Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study. Am J Respir Crit Care Med, 2021, 203(10):1245-1256. doi:10.1164/rccm.202003-0532OC.
[11]	Annesi-Maesano I, Maesano CN, Biagioni B, et al. Call to action: Air pollution, asthma, and allergy in the exposome era. J Allergy Clin Immunol, 2021, 148(1): 70-72. doi:10.1016/j.jaci.2021.05.026. pmid: 34238507
[12]	Cottin V, Wollin L, Fischer A, et al. Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev, 2019, 28(151): 180100. doi:10.1183/16000617.0100-2018.
[13]	Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J, 2019, 53(5): 1900164. doi:10.1183/13993003.00164-2019.
[14]	Global Initiative for Asthma. USE GRDFP. Geneva: Global Initiative for Asthma, 2023.
[15]	Singh SJ, Baldwin MM, Daynes E, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir Med, 2023, 11(8): 709-725. doi:10.1016/S2213-2600(23)00159-5. pmid: 37216955
[16]	Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet, 2017, 389(10082): 1941-1952. doi:10.1016/s0140-6736(17)30866-8. pmid: 28365056
[17]	National Institute for Health and Care Excellence. Asthma: diagnosis, monitoring and chronic asthma management. London: National Institute for Health and Care Excellence, 2021.
[18]	Nici L, Mammen MJ, Charbek E, et al. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med, 2020, 201(9): e56-e69. doi:10.1164/rccm.202003-0625ST.
[19]	Dasgupta S, Ghosh N, Bhattacharyya P, et al. Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview. Crit Rev Clin Lab Sci, 2023, 60(2): 153-170. doi:10.1080/10408363.2022.2140329.
[20]	Thai AA, Solomon BJ, Sequist LV, et al. Lung cancer. Lancet, 2021, 398(10299): 535-554. doi:10.1016/s0140-6736(21)00312-3. pmid: 34273294
[21]	Vogelmeier CF, Román-Rodríguez M, Singh D, et al. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med, 2020, 166: 105938. doi:10.1016/j.rmed.2020.105938.
[22]	Khan M, Cole AG, Mannino DM. Precision medicine in chronic obstructive pulmonary disease: how far have we come?. Curr Opin Pulm Med, 2022, 28(2): 115-120. doi:10.1097/mcp.0000000000000837.
[23]	MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology, 2021, 26(6): 532-551. doi:10.1111/resp.14041. pmid: 33893708
[24]	Nagase H, Suzukawa M, Oishi K, et al. Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy. Allergol Int, 2023, 72(1): 11-23. doi:10.1016/j.alit.2022.11.008. pmid: 36543689
[25]	Vijverberg SJH, Farzan N, Slob EMA, et al. Treatment response heterogeneity in asthma: the role of genetic variation. Expert Rev Respir Med, 2018, 12(1): 55-65. doi:10.1080/17476348.2018.1403318.
[26]	Sui H, Xu X, Su Y, et al. Gene therapy for cystic fibrosis: Challenges and prospects. Front Pharmacol, 2022, 13: 1015926. doi:10.3389/fphar.2022.1015926.
[27]	朋毛措, 谢俊刚. 免疫细胞在慢性阻塞性肺疾病并发心血管疾病中的研究进展. 结核与肺部疾病杂志, 2024, 5(2): 179-185. doi:10.19983/j.issn.2096-8493.20230118.
[28]	Mattison G, Canfell O, Forrester D, et al. The Influence of Wearables on Health Care Outcomes in Chronic Disease: Systematic Review. J Med Internet Res, 2022, 24(7): e36690. doi:10.2196/36690.
[29]	Zemelka-Wiacek M, Agache I, Akdis CA, et al. Hot topics in allergen immunotherapy, 2023: Current status and future perspective. Allergy, 2024, 79(4): 823-842. doi:10.1111/all.15945.
[30]	Rowan C, Hirten R. The future of telemedicine and wearable technology in IBD. Curr Opin Gastroenterol, 2022, 38(4): 373-381. doi:10.1097/mog.0000000000000845.
[31]	Lim DSC, Kwok B, Williams P, et al. The Impact of Digital Technology on Self-Management in Cancer: Systematic Review. JMIR Cancer, 2023, 9: e45145. doi:10.2196/45145.
[32]	Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med, 2020, 288(5): 518-536. doi:10.1111/joim.13141.

慢性呼吸系统疾病管理的现状和展望

Current status and prospects of management of chronic respiratory diseases

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 32

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	齐威, 赵恩奕. 2006—2020年天津市中心城区老年与非老年肺结核流行特征及变化趋势[J]. 结核与肺部疾病杂志, 2025, 6(1): 46-54.
[2]	廖影, 庞艳, 赵静, 何高琴, 游茂林, 王蕾. 2018—2023年重庆市梁平区肺结核患者报告情况及发现延迟特征分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 8-13.
[3]	蔡晓婷, 杜雨华, 吴桂锋, 何立乾, 苏碧慧, 龚芳, 王挺, 赖铿, 伍小英. 2016—2023年广州市肺结核登记情况及特征分析[J]. 结核与肺部疾病杂志, 2024, 5(5): 430-436.
[4]	薛敏, 魏小玲, 刘苗, 王静, 张赟, 马香. 儿童哮喘起病年龄相关影响因素分析[J]. 结核与肺部疾病杂志, 2024, 5(5): 468-475.
[5]	时旭, 陈如冲, 李靖. 哮喘表型和2型炎症哮喘研究进展[J]. 结核与肺部疾病杂志, 2024, 5(5): 489-494.
[6]	夏军. 2014—2023年江西省上饶市肺结核流行病学特征分析[J]. 结核与肺部疾病杂志, 2024, 5(4): 325-332.
[7]	苏醒岳, 王蓓蕾, 马香. 中国儿童2型炎症型哮喘单核苷酸多态性和相关基因关系的研究进展[J]. 结核与肺部疾病杂志, 2024, 5(4): 370-375.
[8]	谌欣欣, 刘国凤, 杨英姿, 胡亚晨, 金瑛, 李玉梅. 肺癌化疗患者住院期间体力活动水平和症状群的相关性分析[J]. 结核与肺部疾病杂志, 2024, 5(3): 197-206.
[9]	潘琼, 田娅媛, 童斐. 早期肢体主动活动对肺癌患者术后肺栓塞发生的效果分析[J]. 结核与肺部疾病杂志, 2024, 5(3): 212-218.
[10]	字晓慧, 吴芃, 郑苏菲, 孙楠, 赫捷. 低剂量CT筛查对人群肺癌死亡率及全因死亡率影响的Meta分析[J]. 结核与肺部疾病杂志, 2024, 5(2): 106-112.
[11]	张太发, 周华. 2017—2022年江苏省太仓市肺结核流行病学特征分析[J]. 结核与肺部疾病杂志, 2024, 5(1): 64-69.
[12]	尼尔佳玛丽·木塔力甫, 玛力亚·牙生, 克丽别娜·吐尔逊. 支气管哮喘气道炎症表型临床特征及靶向治疗研究进展[J]. 结核与肺部疾病杂志, 2023, 4(6): 506-510.
[13]	汤可, 袁小东, 张来星. 三维建模辅助检出肺部磨玻璃密度结节的临床教学分析[J]. 结核与肺部疾病杂志, 2023, 4(5): 346-351.
[14]	秦雪玲, 陈丽, 党传欣, 李宗芳. 2013—2022年山东省日照市学生肺结核疫情特征分析[J]. 结核与肺部疾病杂志, 2023, 4(5): 357-363.
[15]	孟玮玮, 曾慧卉, 陈燕. 吸气峰流速测定在慢性气道疾病中应用研究进展[J]. 结核与肺部疾病杂志, 2023, 4(5): 391-396.